We are live on ! Find out more
ROSG

Rosetta Genomics Ltd.
ROSG

Delisted

ROSG was delisted on the 21st of May, 2018.

Back to rankings

10 hedge funds and large institutions have $387K invested in Rosetta Genomics Ltd. in 2013 Q2 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less call options, than puts

Call options by funds: $100K | Put options by funds: $108K

Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
$100K
Puts
$108K
Net Calls
-$8K
Net Calls Change
-$8K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ROSG Hedge Fund Activity: Q2 2013 in Review

10 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q2 2013, worth a combined $387K.

Buyers outnumbered sellers: 10 funds opened new ROSG positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.

  • 10 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $387K of Rosetta Genomics Ltd. stock for Q2 2013.
  • 10 funds opened new Rosetta Genomics Ltd. positions in Q2 2013 and 0 closed out, a net change of +10 holders.

Based on aggregated 13F filings for Q2 2013.